LFCR
Price
$6.76
Change
-$0.12 (-1.74%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
176.87M
83 days until earnings call
OGI
Price
$1.31
Change
-$0.02 (-1.49%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
200.85M
Interact to see
Advertisement

LFCR vs OGI

Header iconLFCR vs OGI Comparison
Open Charts LFCR vs OGIBanner chart's image
Lifecore Biomedical
Price$6.76
Change-$0.12 (-1.74%)
Volume$2.31K
Capitalization176.87M
Organigram Global
Price$1.31
Change-$0.02 (-1.49%)
Volume$6.3K
Capitalization200.85M
LFCR vs OGI Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. OGI commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and OGI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (LFCR: $6.88 vs. OGI: $1.34)
Brand notoriety: LFCR and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 36% vs. OGI: 33%
Market capitalization -- LFCR: $176.87M vs. OGI: $200.85M
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while OGI’s TA Score has 3 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 2 bearish.
  • OGI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than OGI.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а -0.29% price change this week, while OGI (@Pharmaceuticals: Other) price change was -0.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.18%. For the same industry, the average monthly price growth was +14.81%, and the average quarterly price growth was +63.21%.

Reported Earning Dates

LFCR is expected to report earnings on Aug 27, 2025.

OGI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.18% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGI($201M) has a higher market cap than LFCR($177M). LFCR YTD gains are higher at: -7.402 vs. OGI (-16.770). LFCR has higher annual earnings (EBITDA): -22.64M vs. OGI (-195.74M). OGI has more cash in the bank: 42.3M vs. LFCR (4.22M). OGI has less debt than LFCR: OGI (136K) vs LFCR (157M). LFCR has higher revenues than OGI: LFCR (188M) vs OGI (161M).
LFCROGILFCR / OGI
Capitalization177M201M88%
EBITDA-22.64M-195.74M12%
Gain YTD-7.402-16.77044%
P/E RatioN/AN/A-
Revenue188M161M117%
Total Cash4.22M42.3M10%
Total Debt157M136K115,441%
FUNDAMENTALS RATINGS
LFCR vs OGI: Fundamental Ratings
LFCR
OGI
OUTLOOK RATING
1..100
7615
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
5247
P/E GROWTH RATING
1..100
443
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (51) in the null industry is somewhat better than the same rating for LFCR (92) in the Industrial Specialties industry. This means that OGI’s stock grew somewhat faster than LFCR’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's SMR Rating (92) in the null industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as LFCR (52) in the Industrial Specialties industry. This means that OGI’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (4) in the Industrial Specialties industry is somewhat better than the same rating for OGI (43) in the null industry. This means that LFCR’s stock grew somewhat faster than OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCROGI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOGX42.010.29
+0.70%
Thornburg Global Opportunities R6
JDVSX16.09N/A
N/A
JPMorgan Diversified I
GPEOX12.11N/A
N/A
Grandeur Peak Emerg Mkts Opps Inv
LAFGX15.60N/A
N/A
Lord Abbett International Growth F
HQIYX21.00N/A
N/A
Hartford Equity Income Y

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+0.15%
SHPH - LFCR
31%
Poorly correlated
+6.64%
ALKS - LFCR
27%
Poorly correlated
+0.86%
OGI - LFCR
27%
Poorly correlated
+0.75%
AMRX - LFCR
27%
Poorly correlated
-3.22%
TLRY - LFCR
27%
Poorly correlated
+2.17%
More